Another approach to blocking the PD-1/PD-L1/2 CD8+ T-cell inactivation focuses on inhibiting the induction of PD-1 on T cells or inhibiting the expression of PD-L1/2 in tumor cells. This evidence concerns the gene CD8A and neoplasm.